| 000 | 01729 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513135232.0 | ||
| 264 | 0 | _c19980306 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0950-9232 | ||
| 024 | 7 |
_a10.1038/sj.onc.1201556 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhmed, M | |
| 245 | 0 | 0 |
_aBCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line. _h[electronic resource] |
| 260 |
_bOncogene _cJan 1998 |
||
| 300 |
_a489-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xphysiology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCell Line _xcytology |
| 650 | 0 | 4 |
_aErythropoietin _xmetabolism |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aInterleukin-3 _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aOncogenes _xphysiology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Erythropoietin _xphysiology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _abcl-2-Associated X Protein |
| 700 | 1 | _aDusanter-Fourt, I | |
| 700 | 1 | _aBernard, M | |
| 700 | 1 | _aMayeux, P | |
| 700 | 1 | _aHawley, R G | |
| 700 | 1 | _aBennardo, T | |
| 700 | 1 | _aNovault, S | |
| 700 | 1 | _aBonnet, M L | |
| 700 | 1 | _aGisselbrecht, S | |
| 700 | 1 | _aVaret, B | |
| 700 | 1 | _aTurhan, A G | |
| 773 | 0 |
_tOncogene _gvol. 16 _gno. 4 _gp. 489-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.onc.1201556 _zAvailable from publisher's website |
| 999 |
_c9453033 _d9453033 |
||